New York, November 01, 2021 –The global cell therapy market is expected to reach USD 9.24 Billion in 2028 and register a steady revenue CAGR of 5.6% over the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth include rising demand for better and more advanced therapies for treating cardiovascular, autoimmune, and neurological diseases, improving healthcare infrastructure, and technological advancements in cell therapy.
Cell therapy is one of the most promising and speedily advancing techniques that aid in repairing damaged or destroyed tissue. It is a cell transplantation therapy in which human cells are injected or grafted into the patient’s body to repair or replace damaged or diseased cells and tissues. Continuous research and innovations in cell therapy has led to the use of different types of cells such as hematopoietic stem cells, mesenchymal stem cells, pancreatic islet cells, lymphocytes for treating various chronic diseases, cancers, autoimmune diseases, urinary problems, and neurological disorders. Factors such as increasing Good Manufacturing Practice (GMP) certification approvals for cell therapy manufacturing, increasing investments for developing enhanced cell therapies, rising awareness about stem cell therapies, improving healthcare infrastructure, and expanding healthcare budget are boosting market growth. In addition, various market players are focusing on developing enhanced therapies for cardiovascular diseases, and cancer is expected to fuel market growth going ahead.
Increasing investments in cell therapeutics research, rising number of clinical trials, and inclining adoption of human cells for cell-based research are key factors driving global market growth
Download PDF Sample Copy @ https://www.reportsanddata.com/sample-enquiry-form/3269
However, high cost of cell therapies, rising concerns about stem cell research and treatment, stringent government regulations, and lack of skilled experts to operate advanced instruments and complex procedures in research laboratories are factors expected to hamper overall market growth going ahead.
Some key highlights of the report:
- Among the therapy type, the autologous segment is expected to register rapid revenue growth over the forecast period. Rapid revenue growth is attributed to increasing prevalence of cancer, autoimmune diseases, cardiac disorders, minimum complications of life-threatening diseases, no risk of graft versus host disease, and easily affordable therapy.
- Based on therapeutic area, the autoimmune disorders segment is expected to register fastest CAGR over the forecast period. Increasing prevalence of various autoimmune diseases worldwide, high adoption of cell therapies for treating autoimmune diseases, ongoing research activities, and increasing investments in developing more enhanced therapies are some key factors driving revenue growth of the segment.
- Based on cell type, the stem cells segment is expected to account for largest revenue share during the forecast period owing to increasing stem cell-based research, rising number of GMP certification approvals, high prevalence of chronic illnesses, and increasing number of stem cell banks across the globe.
- Based on end use, the academic and research institutes segment is expected to register fastest CAGR between 2021 and 2028. Factors such as increasing funds by various public and private organizations, and increasing research-based activities owing to prevalence of various chronic diseases are boosting revenue growth of the segment.
- The cell therapy market in North America is expected to account for largest revenue share over the forecast period owing to large patient pool, rapid advancements in cell therapy, availability of latest treatments, and increasing investments in research-based activities.
- Europe is expected to register steady revenue growth over the forecast period owing to increasing prevalence of various chronic diseases, ongoing research on developing enhanced cell therapies, and increasing grants by various public and private sectors in cell therapy research.
- Kolon TissueGene, Inc., Anterogen Co., Ltd., Inc., JCR Pharmaceuticals Co., Ltd., Castle Creek Biosciences, Inc., Mesoblast Ltd., Medipost Co. Ltd., Stemedica Cell Technologies, Inc., Osiris Therapeutics, Inc., PHARMICELL Co., Ltd., Holostem Terapie Avanzate S.r.l., Tameika Cell Technologies, Inc., Cells for Cells, NuVasive, Inc., Vericel Corporation, Celgene Corporation, Thermo Fisher Scientific Inc., Merck KGaA, and Danaher Corporation are key players profiled in the global market report.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3269
For the purpose of this report, Reports and Data has segmented the global cell therapy market based on therapy type, therapeutic area, cell type, end use, and region:
Therapy Type Outlook (Revenue, USD Billion; 2018-2028)
- Allogenic Stem Cell Therapy
- Autologous Stem Cell Therapy
Therapeutic Area Outlook (Revenue, USD Billion; 2018-2028)
- Malignancies
- Autoimmune Disorders
- Musculoskeletal Disorders
- Dermatology
- Others
Cell Type Outlook (Revenue, USD Billion; 2018-2028)
- Stem Cells
- Bone Marrow
- Umbilical Cord derived
- Adipose derived Stem Cells
- Others
- Non-Stem Cells
End-Use Outlook (Revenue, USD Billion; 2018-2028)
- Hospitals & Clinics
- Regenerative Medicine Centers
- Academic & Research Institutes
Buy Now Premium Research Report – https://www.reportsanddata.com/checkout-form/3269
Regional Outlook (Revenue, USD Billion, 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Similar Research reports by Reports and Data of Pharma and Healthcare Industry:
Cannabidiol (CBD) Market , By Product (Tinctures, Transdermal Patches, Pills & Capsules, Isolates, Suppository, Oil, and Others), By Source (Hemp, Marijuana), By Application (Personal Use, Medical, Food & Beverages, Cosmetics & Personal Care, Nutraceuticals, Others), By Distribution Channel (Offline, Online), and By Region Forecast to 2028
Aesthetic Medicine Market Trends, Share & Size, By Product Type (Energy-Based Devices, Implants, Anti-Wrinkle Products), By Application (Surgical, Non-Surgical), By End-Use (Medical Spas & Beauty Centers, Hospitals & Clinics, Home Use), By Region Forecast To 2028
Antidiabetics Market Size, Trends & Analysis, By Patient Type (Pediatric, Adult, Geriatric), By Application (Type I Diabetes And Type II Diabetes), By Product (Insulin, Drug class), By Administration Mode (Insulin Syringe/Insulin Pen, Insulin Pump, Intravenous Infusion, Oral), By Region, Forecast To 2028
Anxiety Disorder and Depression Treatment Market By Therapies (Cognitive Behavior Therapy (CBT)), By Drug Class (Antidepressant Drugs, Selective Serotonin Reuptake Inhibitors (SSRIs)), By Devices, By Application, and End-users, And Segment Forecasts To 2028
About Reports and Data:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-cell-therapy-market